Heart Failure:
It is a Chronic condition in which heart is not capable to pump blood well enough to meets the body’s needs for blood and oxygen.
Human body depends on the heart’s pumping action to deliver oxygen- and nutrient-rich blood to the body’s cells. When the cells are nourished properly, the body can function normally. With heart failure, the weakened heart can’t supply the cells with enough blood. This results in fatigue and shortness of breath and some people have coughing. Everyday activities such as walking, climbing can become very difficult.
Symptoms:
Prevention: Some factors like Age, family history or race are not in hand to control but by changing the lifestyle to give yourself the best chance of preventing heart failure. Which includes Staying at healthy weight, eating food that is good to the heart, Stress management, regular exercise, by reducing alcohol consumption, etc.
Myocardial Infraction:
Myocardial infarction (MI) refers to tissue death (infarction) of the heart muscle (myocardium) caused by ischaemia, the lack of oxygen delivery to myocardial tissue. It is a type of acute coronary syndrome, which describes a sudden or short-term change in symptoms related to blood flow to the heart. It is also known as heart attack.
Symptoms include tightness or pain in the chest, neck, back or arm as well as fatigue, lightheadness, abnormal heartbeat and anxiety.
Title : Managing total chronic coronary occlusion: Noninvasive External Counterpulsation (ECP) induces collaterogenesis, relieving ischemia, as demonstrated by quantitative PET myocardial perfusion imaging: ECP is a cost-effective alternative to high risk PCI
Michael E Merhige, State University of NY at Buffalo, United States
Title : Effects of impaired microcirculation in the musculoskeletal system
Roger H Coletti, Interventional Health, PA, United States
Title : Cardio nanomedicine: Fighting plaque, opening arteries, and healing hearts
Thomas J Webster, Hebei University of Technology, China
Title : Dopamine D2 receptor and inverse salt sensitivity
Pedro A Jose, The George Washington University of School of Medicine & Health Sciences, United States
Title : Clinical pharmacology of sotagliflozin – Novel quality in treatment of heart failure
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Rationale for the prevention or therapy of sudden cardiac death in heart failure
Naranjan Dhalla, St. Boniface Hospital Albrechtsen Research Centre, Canada